Product Details FAQ Specification Instructions

A wide range of pathogens can cause sexually transmitted infections (STIs), including viruses, chlamydia, mycoplasmas, spirochetes, bacteria, fungi, and protozoa. The symptoms, severity, and impact of STIs vary depending on the pathogen. Some of the most impactful pathogens include Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), Mycoplasma genitalium (Mg), Treponema pallidum (TP), Herpes Simplex Virus types 1 and 2 (HSV1 and HSV2), Ureaplasma urealyticum (UU), Mycoplasma hominis (MH), Gardnerella vaginalis (GV), Trichomonas vaginalis (TV), Haemophilus ducreyi (HD), Ureaplasma parvum (UP), and Candida albicans (CA). According to WHO estimates, around 374 million new cases of chlamydia, gonorrhea, syphilis, and trichomoniasis were reported among those aged 15 to 49 in 2020. In 2022, approximately 8 million adults were infected with syphilis, and over 500 million people worldwide aged 15 to 49 were living with genital herpes.

STIs contribute to stigma, infertility, cancer, and pregnancy complications, directly affecting sexual and reproductive health and increasing the risk of HIV infection. Thus, testing for 13 STI pathogens in male urethral and female cervical swab samples is crucial. This kit is designed for detecting 13 common STI pathogens, including Chlamydia trachomatis, Neisseria gonorrhoeae, and Mycoplasma genitalium, to screen samples for the presence of STI pathogens.

High Accuracy: Effectively detects nucleic acids of 13 STI pathogens, providing results that meet expected standards.

High Specificity: No cross-reactivity with Group B Streptococcus, HPV, Salmonella, CMV, EBV, or HHV-6.

Controls Included: Includes a non-competitive endogenous control to monitor the entire process.

Ease of Use: Pre-portioned, Lyophilized format requires only the addition of nucleic acids for testing.